Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 50 Small Cell Lung Carcinoma 23 Breast Neoplasms 17 Sarcoma 16 Carcinoma, Hepatocellular 10 Lung Neoplasms 9 Esophageal Squamous Cell Carcinoma 9 Stomach Neoplasms 8 Neoplasms 8 Triple Negative Breast Neoplasms 7 Ovarian Neoplasms 7 Nasopharyngeal Carcinoma 7 Neoplasm Metastasis 6 Pancreatic Neoplasms 5 NSCLC 5 Colorectal Neoplasms 5 Carcinoma 5 Uterine Cervical Neoplasms 4 Thyroid Neoplasms 4 Pheochromocytoma 4 Esophageal Neoplasms 4 Endometrial Neoplasms 4 Carcinoma, Renal Cell 4 Carcinoma, Ovarian Epithelial 4 Recurrence 3 Paraganglioma 3 Non-squamous Non-small Cell Lung Cancer 3 Glioma 3 Fallopian Tube Neoplasms 3 Cholangiocarcinoma 3

Interventions

Sorafenib 61 Bevacizumab 42 Oxaliplatin 24 Doxorubicin 22 Radiosurgery 20 Gemcitabine 20 Fluorouracil 20 Nivolumab 19 durvalumab 18 Radiofrequency Ablation 18 pembrolizumab 17 Capecitabine 17 lenvatinib 16 Cisplatin 16 atezolizumab 13 Leucovorin 13 Radiotherapy 11 tremelimumab 10 Cyclophosphamide 10 Carboplatin 10 Irinotecan 9 Ipilimumab 9 Drug Therapy 9 Everolimus 8 Cryosurgery 8 toripalimab 7 fludarabine 7 Sunitinib 7 Chemotherapy, Adjuvant 7 Melphalan 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Liver Neoplasms × anlotinib × Clear all

NCT03766776 2018-12-11

ATAHC

The First Affiliated Hospital with Nanjing Medical University

Phase NA Unknown

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡